(Q44777019)

6 December 2017

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences (English)

1 reference

6 December 2017

0 references

0 references

0 references

Howard C Margolese

1

1 reference

6 December 2017

Leslie Malchy

2

1 reference

6 December 2017

Juan Carlos Negrete

3

1 reference

6 December 2017

Raymond Tempier

4

1 reference

6 December 2017

Kathryn Gill

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

Schizophrenia Research

1 reference

6 December 2017

67

1 reference

6 December 2017

2-3

1 reference

6 December 2017

157-166

1 reference

Schizophrenia, sensory gating, and nicotinic receptors.

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Alcohol abuse in the psychiatric hospital population

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Schizophrenia and violence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Cocaine abuse among schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Substance Abuse in an Inpatient Psychiatric Sample

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Prevalence of substance misuse in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Cannabis and schizophrenia: results of a follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Drug abuse in a young psychiatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Alcoholism and smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Diagnosis of alcohol use disorders in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Treatment of substance abuse in severely mentally ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Schizophrenia and substance abuse: prevalence issues

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Determinants of medication compliance in schizophrenia: empirical and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Patterns of current and lifetime substance use in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Prevalence of substance abuse in psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Substance abuse and the onset of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Compliance with depot antipsychotic medication by patients attending outpatient clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Cigarette smoking among patients with mental retardation and mental illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Reliability and validity of the positive and negative syndrome scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Individual changes in clozapine levels after smoking cessation: results and a predictive model

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Newer antidepressants and the cytochrome P450 system

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Predicting medication noncompliance after hospital discharge among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

An epidemiologic investigation of alcohol-dependent schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Effects of cocaine on hospital course in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

A rating scale for tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Substance misuse, psychiatric disorder and violent and disturbed behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Prevalence of alcohol and drug abuse in schizophrenic inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Common genetic vulnerability for nicotine and alcohol dependence in men

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Cytochrome P450 enzyme system: genetic polymorphisms and impact on clinical pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900523-6

7 January 2021

10.1016/S0920-9964(02)00523-6

Identifiers

DOI

1 reference

6 December 2017

1 reference